NTRK1 and cervical cancer: Given that angiogenesis is a key feature in gynecological neoplasms, and NTs act as direct and indirect angiogenic factors, it may be relevant to study whether TRK inhibitors can improve the efficacy of antiangiogenic drugs, especially in cervical cancers with a co-existing HIV infection.